Literature DB >> 18042571

A comparison of methods for fixed effects meta-analysis of individual patient data with time to event outcomes.

Catrin Tudur Smith1, Paula Ruth Williamson.   

Abstract

BACKGROUND: Alternative methods for individual patient data (IPD) meta-analysis of time-to-event outcomes have been established and utilized in practice. The most common approach is a stratified log-rank analysis. The IPD approach is considered to be the gold standard approach for meta-analysis and is becoming increasingly more popular but the performance of different methods has not been studied previously.
PURPOSE: To compare commonly used methods for fixed effects meta-analysis of individual patient time-to-event data.
METHODS: The stratified log-rank analysis, an inverse variance weighted average of Cox model estimates, and the stratified Cox regression model are compared. First, a theoretical comparison of approaches is undertaken. Second, the bias and coverage are assessed for the pooled hazard ratio using simulated data under commonly encountered meta-analysis conditions. Finally, a comparison is presented using empirical data from four separate systematic reviews of anti-epileptic drug trials where IPD are available for two time-to-event outcomes.
RESULTS: For hazard ratio close to 1 with minimal heterogeneity between trials, theoretical results suggest similar results should be expected from all the three methods. Results for empirical and simulated data are in keeping with the theoretical results and show all the three methods perform well under these conditions. When there is no heterogeneity and the proportional hazards assumption holds, the stratified Cox model and inverse variance weighted average produce similar estimates of the pooled treatment effect and are to be preferred to the stratified log-rank analysis when the underlying treatment effect is large. Coverage values diminish for all the three methods and are below 95% for low or moderate heterogeneity. The low coverage values highlight the need for models that appropriately account for or explore the between trial variation. LIMITATIONS: Until larger simulations can be undertaken, conclusions based on the simulated and empirical data should only be applied to small meta-analyses of four or five trials.
CONCLUSIONS: These investigations suggest that under normal conditions all three methods provide similar results. For moderate heterogeneity coverage for all the three fixed effects models depreciates.

Entities:  

Mesh:

Year:  2007        PMID: 18042571     DOI: 10.1177/1740774507085276

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  19 in total

1.  Analysis of Partially Incomplete Tables of Breast Cancer Characteristics with an Ordinal Variable.

Authors:  B Nebiyou Bekele; Luis E Nieto-Barajas; Mark F Munsell
Journal:  J Stat Theory Pract       Date:  2012-12

2.  Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data.

Authors:  Mariann Gyöngyösi; Wojciech Wojakowski; Patricia Lemarchand; Ketil Lunde; Michal Tendera; Jozef Bartunek; Eduardo Marban; Birgit Assmus; Timothy D Henry; Jay H Traverse; Lemuel A Moyé; Daniel Sürder; Roberto Corti; Heikki Huikuri; Johanna Miettinen; Jochen Wöhrle; Slobodan Obradovic; Jérome Roncalli; Konstantinos Malliaras; Evgeny Pokushalov; Alexander Romanov; Jens Kastrup; Martin W Bergmann; Douwe E Atsma; Axel Diederichsen; Istvan Edes; Imre Benedek; Theodora Benedek; Hristo Pejkov; Noemi Nyolczas; Noemi Pavo; Jutta Bergler-Klein; Imre J Pavo; Christer Sylven; Sergio Berti; Eliano P Navarese; Gerald Maurer
Journal:  Circ Res       Date:  2015-02-19       Impact factor: 17.367

Review 3.  Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data.

Authors:  Julia Bohlius; Kurt Schmidlin; Corinne Brillant; Guido Schwarzer; Sven Trelle; Jerome Seidenfeld; Marcel Zwahlen; Mike J Clarke; Olaf Weingart; Sabine Kluge; Margaret Piper; Maryann Napoli; Dirk Rades; David Steensma; Benjamin Djulbegovic; Martin F Fey; Isabelle Ray-Coquard; Volker Moebus; Gillian Thomas; Michael Untch; Martin Schumacher; Matthias Egger; Andreas Engert
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

4.  Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials.

Authors:  John G F Cleland; Karina V Bunting; Marcus D Flather; Douglas G Altman; Jane Holmes; Andrew J S Coats; Luis Manzano; John J V McMurray; Frank Ruschitzka; Dirk J van Veldhuisen; Thomas G von Lueder; Michael Böhm; Bert Andersson; John Kjekshus; Milton Packer; Alan S Rigby; Giuseppe Rosano; Hans Wedel; Åke Hjalmarson; John Wikstrand; Dipak Kotecha
Journal:  Eur Heart J       Date:  2018-01-01       Impact factor: 29.983

5.  Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis.

Authors: 
Journal:  Lancet       Date:  2021-05-01       Impact factor: 79.321

6.  Individual Participant Data (IPD) Meta-analyses of Randomised Controlled Trials: Guidance on Their Use.

Authors:  Jayne F Tierney; Claire Vale; Richard Riley; Catrin Tudur Smith; Lesley Stewart; Mike Clarke; Maroeska Rovers
Journal:  PLoS Med       Date:  2015-07-21       Impact factor: 11.069

7.  Individual participant data meta-analyses should not ignore clustering.

Authors:  Ghada Abo-Zaid; Boliang Guo; Jonathan J Deeks; Thomas P A Debray; Ewout W Steyerberg; Karel G M Moons; Richard David Riley
Journal:  J Clin Epidemiol       Date:  2013-05-04       Impact factor: 6.437

8.  Individual patient data meta-analysis of beta-blockers in heart failure: rationale and design.

Authors:  Dipak Kotecha; Luis Manzano; Douglas G Altman; Henry Krum; Guliz Erdem; Nicola Williams; Marcus D Flather
Journal:  Syst Rev       Date:  2013-01-18

9.  Sharing individual participant data from clinical trials: an opinion survey regarding the establishment of a central repository.

Authors:  Catrin Tudur Smith; Kerry Dwan; Douglas G Altman; Mike Clarke; Richard Riley; Paula R Williamson
Journal:  PLoS One       Date:  2014-05-29       Impact factor: 3.240

10.  Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis.

Authors:  Béranger Lueza; Federico Rotolo; Julia Bonastre; Jean-Pierre Pignon; Stefan Michiels
Journal:  BMC Med Res Methodol       Date:  2016-03-29       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.